Latest Breaking News On - What we do not know - Page 1 : comparemela.com

New Study Demonstrates Ropeginterferon Alfa-2b-njft Is a Cost-Effective Treatment Option for a Broad Range of Patients with Polycythemia Vera

BURLINGTON, Mass., August 04, 2023 PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TPEx:6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven scientific principles to deliver new biologics in hematology and oncology, today announced the publication of a cost-effectiveness analysis of ropeginterferon alfa-2b-njft (marketed as BESREMi®) in the Journal of Comparative Effectiveness Research. The analysis, titled "Cost-Effectiven

New Study Demonstrates Ropeginterferon Alfa-2b-njft Is a Cost-Effective Treatment Option for a Broad

Analysis published in the Journal of Comparative Effectiveness Research shows ropeginterferon alfa-2b-njft provided a cost-effective benefit in quality-adjusted life years compared to a commonly used treatment pathwayBURLINGTON, Mass. (BUSINESS WIRE) PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia C.

Afgan gazeteci Pentagon'da gözyaşlarına boğuldu: Benim Cumhurbaşkanım nerede?

ABD Savunma Bakanlığı’nda basın toplantısına katılan Afgan gazeteci Nazira Karimi nin sözleri gündeme oturdu. Pentagon Sözcüsü John F. Kirby’ye soru sorduğu sırada gözyaşlarını tutamayan Karimi, Benim Cumhurbaşkanım nerede, Afgan halkına hesap vermeli dedi. ,

Saray İttifakı'nın 'kafe' krizi: AKP'lilerin önerisini MHP'liler reddetti!

Cumhur İttifakı'nda 'kafe' çatlağı